McGlone Suttner Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.33M Sell
1,146
-4
-0.3% -$4.72K 0.15% 69
2026
Q2
$1.38M Buy
1,150
+34
+3% +$34.7K 0.16% 69
2026
Q1
$1.03M Sell
1,116
-30
-3% -$30.4K 0.14% 78
2025
Q4
$1.23M Buy
1,146
+108
+10% +$103K 0.17% 64
2025
Q3
$792K Buy
1,038
+3
+0.3% +$2.23K 0.11% 87
2025
Q2
$807K Sell
1,035
-17
-2% -$13.2K 0.12% 84
2025
Q1
$869K Buy
1,052
+284
+37% +$236K 0.14% 77
2024
Q4
$593K Buy
768
+41
+6% +$33.9K 0.1% 90
2024
Q3
$644K Buy
727
+87
+14% +$78.2K 0.13% 83
2024
Q2
$373K Sell
640
-54
-8% -$43.2K 0.08% 107
2024
Q1
$540K Buy
694
+54
+8% +$38.4K 0.1% 87
2023
Q4
$373K Sell
640
-7
-1% -$4.09K 0.07% 107
2023
Q3
$348K Buy
647
+103
+19% +$53.1K 0.08% 95
2023
Q2
$255K Buy
+544
New +$228K 0.06% 122
2023
Q1
– Sell
-776
Closed -$284K – 146
2022
Q4
$284K Buy
+776
New +$275K 0.09% 103

Other funds holding LLY

McGlone Suttner Wealth Management's LLY Position: Q3 2026 in Review

McGlone Suttner Wealth Management reduced its Eli Lilly (LLY) stake by 0.35% in Q3 2026, selling an estimated $4.72K and leaving 1,146 shares worth $1.33M. The position accounts for 0.15% of the portfolio, ranked #69.

McGlone Suttner Wealth Management first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.38M in Q2 2026. 4,622 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • McGlone Suttner Wealth Management held 1,146 shares of Eli Lilly worth $1.33M as of Q3 2026.
  • McGlone Suttner Wealth Management sold 4 Eli Lilly shares in Q3 2026, an estimated $4.72K.
  • Eli Lilly made up 0.15% of McGlone Suttner Wealth Management's portfolio in Q3 2026, its #69 holding.
  • McGlone Suttner Wealth Management first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • McGlone Suttner Wealth Management's Eli Lilly position peaked at $1.38M in Q2 2026.
  • 4,622 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on McGlone Suttner Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.